Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AGENUS INC.

(AGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about AGENUS INC.
09/17AGENUS : ESMO 2021 - Agenus Presents Updates on Balstilimab Plus Zalifrelimab Combination
PU
09/17ABCELLERA BIOLOGICS : Health Care Stocks Down to End Week
MT
09/17Health Care Stocks Mixed Premarket Friday
MT
09/17AGENUS : Says Cervical Cancer Combination Therapy Shows 'High' Response Rates in Phase 2 T..
MT
09/16Combination of Balstilimab Plus Zalifrelimab Doubles Responses in 2L Cervical Cancer in..
GL
09/14INSIDER SELL : Agenus
MT
09/10AGENUS : New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Co..
AQ
09/10Agenus Inc. Announces New Subsidiary, SaponiQx
CI
09/09AGENUS : to Participate in September Investor Conferences
AQ
09/07AGENUS : B. Riley Raises Agenus' PT to $12 from $11, Says Continued Regulatory Progress to..
MT
08/26AGENUS : Says Drug Shows Reduction in Cervical Cancer in Mid-Stage Study
MT
08/26AGENUS : Balstilimab Monotherapy Data Published in Gynecologic Oncology
AQ
08/26Agenus Inc. Announces Balstilimab Monotherapy Data Published in Gynecologic Oncology
CI
08/09AGENUS : Posts Wider Q2 Loss, Lower Revenue
MT
08/09AGENUS : Q2 Earnings Snapshot
AQ
08/09AGENUS : Corporate Update and Second Quarter 2021 Financial Report
AQ
08/09Agenus Inc. Promotes Julie DeSander to Chief Business Officer
CI
08/09Agenus Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
08/02AGENUS : to Participate in the BTIG Virtual Biotechnology Conference 2021
AQ
07/28AGENUS : MiNK Therapeutics Announces Confidential Submission of Draft Registration Stateme..
AQ
07/26Agenus Inc. Announces Resignation of Adam F. Krauss, Chief Legal Officer and Chief Comp..
CI
07/26AGENUS : to Provide Corporate Update and Second Quarter 2021 Financial Report
AQ
07/09Agenus Inc. acquired Biomanufacturing Center in Vacaville California, US State from A.G..
CI
07/07Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech..
GL
07/06AGENUS : Says FDA Accepts Investigational New Drug Application for Cancer Drug Candidate; ..
MT
07/06Agenus Closes $200M Upfront BMS Collaboration and Announces FDA Acceptance of IND for P..
GL
07/06Agenus Inc. Announces the U.S. Food and Drug Administration Clearance of an Investigati..
CI
07/06Agenus Inc. Announces the Closing of its Global Exclusive License with Bristol Myers Sq..
CI
06/29AGENUS : B. Riley Raises Agenus' PT to $11 from $8, Notes Value Accretive Catalysts; Keeps..
MT
06/21AGENUS : to Participate in the Raymond James 2021 Human Health Innovation Conference
AQ
06/17Bristol-Myers, Eisai in up to $3.1 billion deal to develop cancer drug candidate
RE
06/17AGENUS' : Biologics License Application for Balstilimab Accepted by FDA for Priority Revie..
MT
06/17Agenus Announces U.S. FDA Acceptance and Priority Review of Balstilimab Biologics Licen..
GL
06/17Agenus Announces U.S. Fda Acceptance and Priority Review of Balstilimab Biologics Licen..
CI
06/17Agenus Gets FDA Priority Review of Balstilimab in Cervical Cancer
DJ
06/15Agenus Announces Virtual Annual Shareholders Meeting
GL
06/04AGENUS : Says Trial of Agen2373 Antibody in Advanced Solid Tumors Showed No Liver Toxicity
MT
06/04Agenus' Presentations at ASCO 2021 Demonstrate Differentiated Activity of Balstilimab a..
GL
06/04Agenus Inc.’ Presentations at ASCO 2021 Demonstrate Differentiated Activity of Balstili..
CI
06/01AGENUS : to Participate in Fireside Chat at the Jefferies 2021 Virtual Healthcare Conferen..
AQ
05/20AGENUS : Presents New Data on Balstilimab and AGEN2373 in ASCO Abstracts
AQ
05/20Agenus Presents New Data on Balstilimab and AGEN2373 in ASCO Abstracts
CI
05/19AGENUS : View Transcript
PU
05/18UPDATE : Agenus Soars After Granting Bristol-Myers Global Exclusive License For Anti-Tumor..
MT
05/18Agenus Shares Rally on Bristol Myers Licensing Deal
DJ
05/18AGENUS : Grants Bristol-Myers Global Exclusive License For Anti-Tumor Drug Candidate
MT
05/18AGENUS : Bristol Myers to pay up to $1.56 bln to develop, sell Agenus's cancer therapy (Ma..
RE
05/18AGENUS : to receive a $200 million upfront payment and up to $1.36 billion in milestone pa..
PU
05/18Agenus Inc. Enters into a License, Development and Commercialization Agreement
CI
05/18Agenus to Host Conference Call to Discuss Global Licensing Agreement with Bristol Myers..
GL
05/18BRISTOL MYERS SQUIBB : Agenus and Bristol Myers Squibb Announce Exclusive Global License f..
AQ
05/18Bristol-Myers Licenses Agenus AGEN1777 Program
DJ
05/06AGENUS : Q1 Earnings Snapshot
AQ
05/06AGENUS : Earnings Flash (AGEN) AGENUS Reports Q1 Revenue $11.7M, vs. Street Est of $14.5M
MT
05/06Agenus Corporate Update and First Quarter 2021 Financial Report
GL
05/06Agenus Inc. Provides A Corporate Update
CI
05/05Agenus Inc. Announces Unaudited Earnings Results for the First Quarter Ended March 31, ..
CI
04/28Agenus to Present at the 2021 ASCO Annual Meeting
GL
04/22Agenus to Provide Corporate Update and First Quarter 2021 Financial Report
GL
04/19AGENUS : Submits Biologics License Application for Balstilimab to Treat Cervical Cancer
MT
04/19AGENUS : Submits Balstilimab Biologics License Application to the U.S. FDA for Patients wi..
AQ
04/19Agenus Inc. Submits Balstilimab Biologics License Application to the U.S. FDA for Patie..
CI
04/14AGENUS : Doses First Patient in Study of Cell Therapy Against Certain Cancers
MT
04/14Agenus Doses First Cancer Patient with iNKT Cell Therapy
GL
04/14Agenus Doses First Cancer Patient with iNKT Cell Therapy
CI
04/10New Clinical Responses for AGEN1181 Presented at AACR
GL
04/06Agenus Inc. Announces Management Changes
CI
04/06AGENUS : to Participate in Webcast Hosted by William Blair on AGEN1181 and Balstilimab AAC..
AQ
04/05INSIDER TRENDS : Agenus Insider Gets Stock Award, Prolongs Buy Trend
MT
04/05INSIDER TRENDS : Agenus Insider Receives Stock Award, Trend of Buys Extended
MT
03/16Agenus Inc. Auditor Raises 'Going Concern' Doubt
CI
03/15AGENUS : Q4 Loss Narrows; Revenue Drops
MT
03/15AGENUS : Q4 Earnings Snapshot
AQ
03/15Agenus Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
GL
03/15Agenus Inc. Provides Corporate Update for Balstilimab (Anti-PD-1), Agen1181, Agen1777 (..
CI
1  2  3  4  5  6Next
Upcoming event on AGENUS INC.
11/09/21
Upcoming sector events